This week was monumental in the future of biotech. CRISPR Therapeutics reported the results of its gene editing study on humans and the results are better than expected. The Nasdaq Biotech Index is breaking out and setting up for a big 2020. Matt recaps his favorite themes he came across at the world’s largest tech conference in Portugal. The show wraps up with an update on cannabis stocks as they start to rally from a multi-year low.